Vascular occlusion following hyaluronic acid injection: A case report.

IF 0.7 4区医学 Q4 MARINE & FRESHWATER BIOLOGY

Undersea and Hyperbaric Medicine Pub Date : 2026-01-01

Recep Özkan, Buyçe Kaya, Güven Kaya

{"title":"Vascular occlusion following hyaluronic acid injection: A case report.","authors":"Recep Özkan, Buyçe Kaya, Güven Kaya","doi":"","DOIUrl":null,"url":null,"abstract":"Introduction: This case presentation discusses vascular occlusion following hyaluronic acid (HA) injection and the subsequent treatment.Case report: A 52-year-old female underwent a 0.2 ml HA filler injection for aesthetic purposes in the forehead area, followed by the development of discoloration and severe pain extending from the glabellar region to the forehead.Discussion: The diagnosis was determined as vascular occlusion due to the injection, and the patient received 300 IU of hyaluronidase immediately. Additionally, hyperbaric oxygen treatment (HBO₂) was initiated. The patient received seven HBO₂ treatments and healed without developing post-treatment necrosis. No scar formation was observed at the three-month follow-up. This case highlights the potential benefits of HBO₂ in managing complications arising from HA fillers. It underscores the importance of physicians performing aesthetic procedures, being attentive to facial anatomy and injection techniques to prevent such complications. Furthermore, having knowledge about the effectiveness of HBO₂ in potential complication scenarios and collaboration with hyperbaric clinics when necessary are recommended.","PeriodicalId":49396,"journal":{"name":"Undersea and Hyperbaric Medicine","volume":"53 1","pages":"47-50"},"PeriodicalIF":0.7000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Undersea and Hyperbaric Medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MARINE & FRESHWATER BIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This case presentation discusses vascular occlusion following hyaluronic acid (HA) injection and the subsequent treatment.

Case report: A 52-year-old female underwent a 0.2 ml HA filler injection for aesthetic purposes in the forehead area, followed by the development of discoloration and severe pain extending from the glabellar region to the forehead.

Discussion: The diagnosis was determined as vascular occlusion due to the injection, and the patient received 300 IU of hyaluronidase immediately. Additionally, hyperbaric oxygen treatment (HBO₂) was initiated. The patient received seven HBO₂ treatments and healed without developing post-treatment necrosis. No scar formation was observed at the three-month follow-up. This case highlights the potential benefits of HBO₂ in managing complications arising from HA fillers. It underscores the importance of physicians performing aesthetic procedures, being attentive to facial anatomy and injection techniques to prevent such complications. Furthermore, having knowledge about the effectiveness of HBO₂ in potential complication scenarios and collaboration with hyperbaric clinics when necessary are recommended.

本刊更多论文

透明质酸注射后血管闭塞1例。

本病例报告讨论透明质酸（HA）注射后血管闭塞及后续治疗。病例报告：一名52岁女性因美观目的在前额区域注射了0.2 ml HA填充剂，随后出现从眉间区延伸到前额的变色和剧烈疼痛。讨论：诊断为注射所致血管闭塞，立即给予300 IU透明质酸酶治疗。此外，开始了高压氧治疗（HBO₂）。患者接受了7次HBO 2治疗，治愈后没有出现坏死。随访3个月未见瘢痕形成。本病例强调了HBO₂在处理HA填充物引起的并发症方面的潜在益处。它强调了医生进行美容手术的重要性，注意面部解剖和注射技术，以防止此类并发症。此外，建议了解HBO₂在潜在并发症情况下的有效性，并在必要时与高压氧诊所合作。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Undersea and Hyperbaric Medicine 医学-海洋与淡水生物学

CiteScore

1.60

自引率

11.10%

发文量

审稿时长

>12 weeks

期刊介绍： Undersea and Hyperbaric Medicine Journal accepts manuscripts for publication that are related to the areas of diving research and physiology, hyperbaric medicine and oxygen therapy, submarine medicine, naval medicine and clinical research related to the above topics. To be considered for UHM scientific papers must deal with significant and new research in an area related to biological, physical and clinical phenomena related to the above environments.